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Abstract
Amyloid fibrils are b-sheet-rich protein aggregates commonly found in the organs and tissues of patients with various
amyloid-associated diseases. Understanding the structural organization of amyloid fibrils can be beneficial for the search of
drugs to successfully treat diseases associated with protein misfolding. The structure of insulin fibrils was characterized by
deep ultraviolet resonance Raman (DUVRR) and Nuclear Magnetic Resonance (NMR) spectroscopy combined with
hydrogen-deuterium exchange. The compositions of the fibril core and unordered parts were determined at single amino
acid residue resolution. All three disulfide bonds of native insulin remained intact during the aggregation process,
withstanding scrambling. Three out of four tyrosine residues were packed into the fibril core, and another aromatic amino
acid, phenylalanine, was located in the unordered parts of insulin fibrils. In addition, using all-atom MD simulations, the
disulfide bonds were confirmed to remain intact in the insulin dimer, which mimics the fibrillar form of insulin.
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Introduction
Protein aggregates play an important role in living cells due to
their ubiquity. Aggregation of proteins results in the formation of
long, unbranched b-sheet-rich structures, commonly known as
amyloid fibrils [1]. These fibrils are found as deposits in the tissues
and organs of patients with various amyloid-associated diseases,
such as Alzheimer’s disease (AD), Parkinson’s disease (PD),
Huntington’s disease (HD), prion disease, and type II diabetes
[2,3]. There is also increasing evidence that small aggregates of
misfolded proteins are most toxic and the formation of amyloid
fibrils is a defense mechanism [4]. It is known that more than 20
proteins that can aggregate to form amyloid-like fibrils. Previously,
it was proposed that the ability to form amyloid fibrils is not a
peculiarity of this small group of disease-related proteins, but
rather, the ability to form amyloids is a generic property of the
polypeptide chain [5]. Thus, many physiochemical properties of
protein sequences, such as charge, hydrophobicity, and the
tendency to form secondary structures, were extensively elucidated
in recent decades to understand their relative propensities for
amyloid fibril formation. One example of these properties is
disulfide bonds, which are present in 65% of all secreted proteins,
and in 50% of proteins involved in amyloidosis [6].
The behavior of disulfide bonds upon protein aggregation has
been extensively studied over the past decade [7,8,9]. Disulfide
bonds limit the way in which a protein or a peptide can aggregate
into a fibril via steric restraint. For example, the reduction of intra-
molecular disulfide bonds in b2 microglobulin was determined to
limit the formation of long fibrils upon protein aggregation [9,10].
In our previous work, we demonstrated that a reduction of three
out of four disulfide bonds in bovine apo-a-lactalbumin leads to
significant changes in the aggregation pathways of these proteins,
as well as the structure and morphology of their mature fibrils
[11].
There is great interest in understanding the influence of
disulfide bonds on the stability of insulin. The polypeptide
hormone insulin stimulates a complex signal transduction pathway
associated with glucose metabolism. The native structure of the
insulin monomer is mainly helical, with two of its polypeptide
chains linked by one intra-chain and two inter-chain disulfide
bonds. Importantly, disulfide bonds are critical for the physiolog-
ical function of insulin [12]. Insulinoma and injection amyloidosis
are associated with insulin aggregation [13,14]. Zako et al. showed
that reducing all disulfide bonds of native insulin leads to the
formation of structurally and morphologically different insulin
fibrils [15]. In addition to the dramatic impact on insulin stability
and aggregation, disulfide bonds can contribute to free radical
formation and fibrillar toxicity. In particular, Scho ¨neich proposed
that sulfur-containing amino acids cause free radical shrapnel
during protein aggregation [16]. However, whether disulfide
bonds undergo cross-scrambling during insulin aggregation, their
role in this process, and their location in the fibrillar structure
remain unknown.
Insulin is present as a dimer in solution. However, only the
insulin monomer is physiologically active [17]. Insulin dimeriza-
tion has been proposed as a key step in the amyloidogenic pathway
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e36989[18]. Belfort et al. proposed that three dimers of insulin comprise
the fibril precursors that function as a template for further insulin
aggregation [19]. Insulin fibrils are b-sheet-rich aggregates,
whereas native insulin has a predominantly a-helical structure.
Thus, an extensive a-helical to b-sheet refolding should occur
during the fibrillation process. The elucidation of the amyloido-
genesis of the insulin sequence, which is a primary determinant in
protein aggregation, has been a topic of active research in recent
decades [20,21,22]. New possibilities could be created for specific
drug design to block insulin aggregation and fibril formation.
Eisenberg et al. proposed that part of the B-chain sequence,
LVEALYL, is the smallest segment responsible for the initiation of
insulin aggregation [18]. However, this segment has also been
determined to terminate protein aggregation. Previous studies by
Sawaya et al. have demonstrated that several other sequences, such
as LYQLEN (residues A13–A18) and VEALYL (residues B12–
B17), also modify protein aggregation and form amyloid fibrils
[23,24]. In addition, point mutations have been found to either
delay or prolong the lag phase of insulin fibrillation [21,22].
However, whether the studied amino acid fragment is located in
parts of the unordered fibril or forms the core spine remains
elusive.
Hydrogen-deuterium (H/D) exchange is a valuable tool for
characterizing protein structure, solvation, and water exposure
when combined with NMR, mass spectrometry, and vibrational
spectroscopy. Coupling NMR with H/D exchange has been
demonstrated to be a powerful method for determining the amino
acid motif involved in b2 microglobulin fibril formation [25]. Deep
UV resonance Raman spectroscopy combined with H/D has also
been shown to be a very powerful tool for fibril core character-
ization [26,27]. In an amino acid residue, the main chain NH
group and O-, N-, and S-bound protons exchange easily, whereas
carbon-bound hydrogens do not. In the hydrophobic core or
strongly hydrogen-bonded secondary structures of proteins, the
H/D exchange rates are strongly reduced due to the shielding of
exchangeable sites. Previously, the hydrophobic fibril core was
demonstrated to be highly resistant to H/D exchange [27]. The
current model of amyloid fibrils postulates that a highly
hydrophobic cross-b core is flanked by unordered parts. Taking
this model into account, one can expect that hydrogen-deuterium
exchange of these fibril structures will result in the proton
exchange only in unordered parts, whereas the cross-b core
remains protonated.
Herein, using the combination of deep ultraviolet resonance
Raman (DUVRR) and Nuclear Magnetic Resonance (NMR)
spectroscopy with H/D exchange, we determined the parts of the
insulin sequence that form the fibril core and are present in the
unordered parts. We observed that at least two B-chain segments,
B3–B7 and B10–B18, remain highly protonated under H/D
exchange and most likely form the fibril core. Surprisingly, we did
not observe any highly protonated segments in the insulin A-chain
that were longer than two amino acid residues. We also found that
one cysteine residue of each disulfide pair is located in the
hydrophobic fibril core, whereas the other residue sticks out of the
fibril core and is most likely located in the unordered parts of the
fibril. This discovery demonstrates that fibril disulfide bonds
remain intact with the same molecular conformation as in native
insulin, even after an extensive conversion of the a-helical
structure to a fibrillar b-sheet. One can envision that during
protein aggregation, cysteine disulfide bonds extend out into the
aqueous media, whereas tyrosines are packed inside the fibril
cross-b core. We performed MD simulations in aqueous solution
to model the conversion of mainly a-helical monomers into
primary b-sheet dimers. Our results indicate that the monomer
aggregation process occurs via a zipper-like mechanism as
previously proposed by Eisenberg and co-workers [18]. The
complete melting of a-helices and the formation of a significant
amount of b-sheets occur, although all three disulfide bonds of
native insulin remain intact.
Results and Discussion
Determination of Amino Acid Protection
After the termination of insulin fibrillation, mature insulin
fibrils, separated from un-aggregated protein, were re-dispersed in
D2O, pD* 1.9 at 25uC. Deuterium atoms were substituted for
hydrogen atoms in fibril unordered parts, while the highly
hydrophobic core remained protonated. Our microscopic obser-
vation of insulin fibrils before and after H/D exchange did not
show any noticeable changes in their morphology (Figure S1). The
exchanged fibril solution was then lyophilized and re-dissolved in a
buffer composed of 99.95% DMSO and 0.05% TFA, which
disintegrates the fibril structure into protein monomers (Figure S2)
without changing the protonation state of amide protons. The
resulting protein was then analyzed by homonuclear NMR
spectroscopy. The un-exchanged amides from the amino acids
that were localized in the fibril core were detected, and the amino
acid residues that exchanged a proton for a deuterium were
‘‘invisible.’’ To determine the degree of protection for each residue
that remained protonated, the peak intensities of insulin that was
incubated with and without D2O were plotted against the residue
number (Figure 1 and Figure S3). The following three thresholds
were established to illustrate the degree of protection: yellow,
ID2O/IH2O $0.75; red, 0.75.ID2O/IH2O$0.675; and blue,
0.675.ID2O/IH2O$0.60 (Figure 1a and b).
Because a native source of insulin was used, we could not
isotopically enrich insulin with NMR-active nuclei, such as
13C
and
15N, which help facilitate the chemical shift assignment
process [28]. Therefore, 2D
1H,
1H-total correlation spectroscopy
(TOCSY) and nuclear Overhauser effect spectroscopy (NOESY)
were used for the sequence-specific assignment of the chemical
shifts of protons in the amino acid residues of the protein.
1H,
1H
TOCSY experiments were used to determine the types of amino
acid residues that were present.
1H,
1H NOESY experiments were
used to place residues within the protein primary sequence for
sequence-specific assignments [29].
The spectral dispersion of insulin in the amide proton region
was limited, ranging from 7.1 ppm to 8.8 ppm (Figure 1c), which
is a strong indication that insulin is largely devoid of tertiary
structure under the NMR buffer conditions. This relatively narrow
spectral region leads to the significant spectral overlap of proton
resonances, complicating the chemical shift assignment. When
analyzing the fibril monomer, we unambiguously assigned 35 of
the 49 amino acid insulin residues resolved in 2D
1H,
1H-TOCSY
spectra. However, 14 residues (A chain: Cys
6, Cys
7, Ser
9, Ser
12,
Tyr
14, Leu
16, Asn
18, Cys
20; B chain: Phe
22, Gly
29, Ser
30, Gly
41,
Gly
44, Phe
45) were missing and could not be assigned due to either
spectral overlap or extreme line broadening caused by the
intermediate exchange between conformers in solution. It is also
possible that amino acid residues located in unordered fibril parts
exchanged with deuterium at rates that were too fast to be
detected by NMR spectroscopy.
Only two amino acid doublets, Ile
2-Val
3 and Val
10-Cys
11, in the
A-chain were observed to be protected to a medium and low
extent (60–75%). In the rest of the A-chain, four single amino
acids, Gln
15, Glu
17, Tyr
19 and Asn
21, were observed to have high
(over 75%) protection, and Leu
13 was observed to have medium
(67.5 to 75%) protection. Interestingly, these amino acid residues
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numbers: Ser
12, Tyr
14, Leu
16, Asn
18 and Cys
20. One might expect
that the protected amino acid residues from the A-chain form the
core spine, whereas the rest of the residues (57%) are most likely
located in the unordered parts of the fibril.
In the B-chain, most amino acid residues (73%) are protected.
We identified two segments [(Asn
3, Gln
4, His
5, Leu
6 and Cys
7);
(His
10, Leu
11, Val
12, Glu
13, Ala
14, Leu
15, Tyr
16, Leu
17, Val
18 and
Cys
19 )] that remain protonated under H/D exchange. Close to
the N-terminus, three amino acids (Phe
25, Tyr
26 and Thr
27) along
with Lys
29 and Ala
30 are also protonated to medium and high
extents. Among the protonated amino acid residues of the B-chain,
there is an LVEALYLV segment predicted by Eisenberg to be the
main contributor to the fibrillar core formation [18]. We also
found that the following N-termini of both chains are protected:
Asn
21 of the A-chain and Ala
30 of the B-chain to a medium and a
high extent, respectively. However, the C-termini of both chains
remain unprotected, suggesting that the protein C-terminus is
located outside the core, whereas the N terminus takes part in
fibrillar core formation. Our calculations show that in both A- and
B-chains, 61% of the insulin sequence remains protonated and
located in the fibril core. We also determined that three of four
tyrosine residues were protected and were most likely present in
the hydrophobic fibril core. However, another aromatic amino
acid, phenylalanine, remained mostly unprotected (only one of
three amino acid residues is protected) in the fibril structure.
Three disulfide bridges have been shown to play a vital role in
the stability of the insulin monomer. Taking into account the
dramatic perturbation of the insulin secondary structure from an
a-helix into a b-sheet upon protein aggregation, the stability of the
disulfide bridges during this process was investigated. Prior to this
study, there was no experimental evidence about the scrambling or
stability of these bridges [7,8]. Our results show that insulin fibrils
have an intriguing organization of cysteine such that one of each
cysteine pair is protected (Cys
11, Cys
7 and Cys
19), and the other is
not (Cys
6, Cys
7, and Cys
20). We found that Cys
11, Cys
7 and Cys
19
have a higher degree of protection of 60% for H/D exchange and
are most likely located in the hydrophobic fibril core. These data
suggest that each unprotected cysteine may ‘‘follow’’ its protected
partner, which is integrated into the b-sheet core, during
secondary structure changes, leaving the disulfide bond intact.
Therefore, we hypothesized that the unordered parts of the fibril
contain cysteine and are rich in disulfide bonds. One might
speculate that the specific location of cysteine may play a role in
intertwining proto-filaments and proto-fibrils. As a result, Raman
spectroscopy was used to investigate the conformations of disulfide
bridges in native insulin and insulin fibrils.
The Conformations of Disulfide Bonds
There are three disulfide bonds that maintain the structure of
the insulin monomer. Their scrambling and stability upon
fibrillation have been extensively studied [7,8,13]. Raman
spectroscopy is a unique technique used in the structural
characterization of protein disulfide bond conformations. Struc-
tural information can be obtained regarding the internal rotation
of C-C-S-S-C-C bonds that are present in the following
Figure 1. The majority of H/D exchange-protected amino acids are located in the B-chain of insulin. The amino acids in the 3D structure
(A) and primary sequence of insulin fibrillar monomer (B) are colored according to the following degree of H/D exchange protection: yellow, ID2O/
IH2O$0.75; red, 0.75.ID2O/IH2O$0.675; and blue, 0.675.ID2O/IH2O$0.60. Gray (in the 3D structure) and white colors (in the primary sequence) indicate
unprotected (exchanged) amino acids. (C) 2D
1H,
1H-TOCSY spectrum of insulin fibrillar monomer in DMSO and 0.05% TFA at 30uC after a 7-day D2O
exchange at room temperature. NMR data were acquired at room temperature on a Bruker Avance II 500 MHz NMR spectrometer equipped with a
cryoprobe.
doi:10.1371/journal.pone.0036989.g001
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trans (g-g-t), and trans-gauche-trans (t-g-t) [30]. Using non-
resonance Raman spectroscopy with excitation at 785 nm, we
determined that the predominant gauche-gauche-gauche (g-g-g)
conformation for all fibril disulfide bonds is identical to that of
disulfide bonds in the native protein (peak at 510 cm
21, Figure 2).
These data indicate that all three disulfide bonds do not break,
and all three keep the predominant gauche-gauche-gauche
conformation of the C-C-S-S-C-C segment. Insulin aggregates
and preserves its disulfide bonds by squeezing one cysteine residue
in each disulfide bond outside the fibril core to the flexible
unordered parts. Based on this observation, we hypothesized that
the surface of the insulin fibrils should be rich with cysteine
residues and disulfide bonds, which may play a significant role in
the high free radical activity that is associated with sulfur atoms
[16]. Additionally, the NMR data support the conclusion that
disulfide bonds do not scramble during insulin aggregation. The
scrambling of disulfide bonds would lead to changes in the
orientation of the protein backbone around these cysteine residues,
resulting in large chemical shifts for the affected residues. We
observed that the amino acid peak positions within the vicinity of
cysteine residues in the 2D
1H,
1H-TOCSY spectra of an insulin
fibril monomer and native protein are similar, indicating that the
disulfide bonds did not scramble upon protein aggregation (Figure
S4). Our NMR and Raman data provide new insights about
insulin fibril surface organization, which may serve as a basis for
the design of therapeutic drugs.
Secondary Structure of the Fibril Core
Deep UV resonance Raman spectroscopy has been demon-
strated to be a powerful tool for the characterization of the
amyloid fibril structure [31]. In particular, DUVRR spectroscopy
combined with hydrogen-deuterium exchange has been utilized
in the structural characterization of the fibril core [27]. A typical
protein DUVRR spectrum is dominated by amide bands, which
characterize the polypeptide backbone conformation. In addi-
tion, the spectrum displays aromatic amino acid bands, which
provide information about their local environment [32]. We
observed a gradual increase in Raman band intensity with
incubation time for Ca–H (1390 cm
21) as well as Amide I and II
modes, indicating b-sheet formation. A significant decrease in
tyrosine band intensity was also observed, indicating the changes
in the local environments of tyrosine residues during protein
aggregation (Figure 3, A).
Previous studies of native insulin conformation have indicated
that tyrosines have a hydrophilic environment [33,34]. The
decrease in the intensity of aromatic bands in the DUVRR
spectrum of insulin fibrils could indicate that tyrosine residues are
in a more hydrophobic environment than in the native protein.
However, a significant change in the phenylalanine (1000 cm
21)
band intensity was not observed, indicating that the local
environments of phenylalanine residues do not change. These
data corroborate our NMR results on the aromatic amino acid
environments.
In an unordered protein spectrum, Mikhonin and Asher showed
that H/D exchange caused a downshift of the amide II DUVRR
band from 1555 to 1450 cm-1 (Amide II’) and the virtual
disappearance of the amide III band [35]. Figure 3 B illustrates
the corresponding spectral changes in the DUVRR signature of
insulin fibrils upon deuteration. The deuteration of mature insulin
fibrils resulted in a slight decrease in Amide II band intensity,
indicating that the amount of fibril protein available for
deuteration was very small. This finding is also corroborated by
the relatively small intensity of the Amide II band in the fibril
spectrum compared with that of unfolded insulin completely
exposed to H/D exchange. The unfolded state of insulin was
achieved by dissolution of bovine insulin in D2O, pD 1.0 and brief
heating at 95uC for several minutes.
Based on our observations, insulin fibrils mainly consist of
highly organized cross-b-sheets with high resistance to H/D
exchange. According to Asher and coworkers, the position of the
Amide III3 band corresponds to the Y dihedral angle. We
observed that insulin fibrils have a single peak centered at
1226 cm
21, which, according to Asher’s semi-empirical approach,
[35] corresponds to b-sheet conformation characterized by a Y
dihedral angle of 134.5u.
Figure 2. Disulfide bonds preserve their conformation upon insulin fibrillation. Raman spectra of native insulin (red) and insulin fibrils
(black) have a peak at 510 cm
21, corresponding to the gauche-gauche-gauche (g-g-g) conformation of disulfide bonds (schematically represented in
the inset).
doi:10.1371/journal.pone.0036989.g002
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According to our experimental data, in addition to tertiary
changes, dramatic secondary structure changes occurred upon
insulin aggregation, although the disulfide bonds remained intact.
An obvious question to address is whether the types of structural
perturbations that take place in the insulin monomer during
fibrillation to satisfy both of these criteria. To demonstrate the
possibility of the conversion of the mainly a-helical monomer into
the predominantly b-sheet-rich fibril form, we performed all-atom
MD simulations in aqueous solution on both monomeric and
dimeric forms of insulin. The latter was constructed to represent
only the fibrillar form of insulin and the existence of other non-
structured oligomeric states was ignored. These simulations
provided both the structure and location of each amino acid
residue at the atomic level. The accuracy of the simulated
structures was validated by comparing them with the available
experimental DUVVR and NMR data reported in this study. The
structures of the full-length insulin were investigated in the
following sequence: monomer R dimer. The most representative
structure obtained from the simulation of the monomeric form was
used to develop models for the dimeric form. The equilibrated
structure of the full-length insulin monomer derived from a 100-ns
MD simulation was found to contain mostly a-helical (49.0%) and
small b-sheet (3.9%) character (Table 1).
This structure is well folded and stabilized by a large number of
hydrogen bonds and hydrophobic interactions between A- and B-
chains, including their N- and C-termini. In order to form a dimer,
the structure must substantially unfold to associate with another
monomer (Figure 4). As discussed in the ‘‘computational
procedure’’ section, this unfolding is accomplished by applying a
constant force on the N- and C-termini of the monomer. During
the unconstrained simulations of the dimer, both insulin mono-
mers undergo significant structural changes.
The time evolution of the 150-ns MD simulation of the dimer
shows that there is a gradual increase in the b-sheet character
compared with that of the monomer (Table 1). In the first 5 ns of
the simulation, the b-sheet content enhanced sharply (3.9 R
31.4%). Subsequently, the following slow increase occurred: 34.3,
39.2, 45.1 and 46.1% at 10, 15, 20 and 120 ns, respectively
(Figure 5). The b-sheet character largely remained unchanged in
the 120–150-ns time period. By contrast, the a-helix character was
significantly reduced from 49.0% to 0.0% (Table 1). Notably,
Figure 3. The secondary structure of insulin changes dramatically from being mostly a-helical in the native protein to highly b-
sheet-rich in the fibrillar form. The local environment of tyrosine residues changes simultaneously during hydrophilic to hydrophobic protein
aggregation. A) DUVRR spectra of bovine insulin at pH 2.0, 25uC (red) incubation solution after 30 min (black) and one hour (blue) of heating at 70uC.
Simultaneously, approximately 75% of the insulin sequence is packed into the cross-b-core, and the remainder forms unordered parts of fibrils. B)
Deep UV resonance Raman spectra of insulin fibrils in H2O (blue), after deuteration (red), and a spectrum of cross-b-sheets (black). The contribution of
aromatic amino acids is quantitatively removed by subtracting the spectra of phenylalanine and tyrosine.
doi:10.1371/journal.pone.0036989.g003
Table 1. The a-helix and b-sheet character of simulated
insulin monomer and dimer.
Structure a-helix character b-sheet character
Monomer 49.0% 3.9%
Dimer 0.0% 43.1%
doi:10.1371/journal.pone.0036989.t001
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both monomers did not interact with each other. However, in
fibrils, these regions most likely associate through b-sheet
interactions with other dimers, increasing the content of this
secondary structure.
Dimerization occurs through a zipper-like mechanism in which
the B10–B18 regions of monomers form two sides of the zipper.
The formation of this type of structure has previously been
observed in the oligomerization of short fragments of insulin and
other amyloidogenic peptides [18,36]. The information provided
by the MD simulations can be combined with the measured H/D
exchange data to elucidate the structure of the insulin fibril. In the
structure of the zipper derived from simulations, Leu
11, Leu
15 and
Leu
17 residues of one monomer interact with their counterparts in
the second monomer through hydrophobic interactions. In
addition, two tyrosine residues (Tyr
19 and Tyr
16 of A and B
chains, respectively) interact with each other through p-p
interactions. Due to His
10, Leu
11, Val
12, Glu
13, Ala
14, Tyr
16,
Leu
17, Val
18, Cys
19, and Gly
20 residues forming the hydrophobic
fibril core, these residues must be protected under H/D exchange.
The location and orientation of all these residues in the simulated
structure were found to be in excellent agreement with current and
previously reported experimental data [18]. In addition, the
protection of free Gln
15, Tyr
19 and Asn
21 residues of the A-chain
and the Phe
25-Pro
28 segment of the B-chain is also in accord with
the collected DUVVR and NMR data. Furthermore, as suggested
by the experimental data, all three disulfide bonds [Cys
6(A)-
Cys
11(A), Cys
7(A)-Cys
7(B), and Cys
20(A)-BCys
19(B)] remained
intact in the dimer. Based on these calculations, we confirmed
that the tertiary and secondary structures of insulin can
dramatically change during oligomerization without breaking
disulfide bonds.
Based on these results, we concluded that the dimeric structure
of full-length insulin is a good model for elucidating several key
structural properties of amyloid fibrils. Dimerization appears to be
a critical step in fibrillation. After dimerization, fibrils can grow
through the stacking.
In conclusion, our new approach of combining NMR and
Raman spectroscopy with MD simulations for characterizing
amyloid fibrils has provided exclusive knowledge about fibril
structure. With single-residue resolution, we determined the amino
acid residues that form the fibril core in addition to those that are
located in the unordered parts of the fibril. We found that most of
the sequence from the B-chain of insulin is highly protected from
H/D exchange, including a segment previously described by
Eisenberg [18]. However, we did not find any long (not longer
than two amino acids) protected segments in the A-chain.
Moreover, the A-chain was observed to have the following
intriguing order of protection: starting from Cys
11 to Asn
21, with
alternating protected and unprotected amino acid residues.
We demonstrated that three out of four tyrosine amino acid
residues packed into the cross-b-sheet during insulin aggregation,
whereas another aromatic amino acid, phenylalanine, remained in
the unordered parts. Based on NMR data, we determined that the
following B-chain residues are highly protected: Phe
25, Tyr
26, and
Thr
27; Lys
29 and Ala
30. In addition, we found that both amino
acids at the insulin C-termini were unprotected, whereas both
amino acids at the N-termini remained highly protonated, packing
into the cross-b-core. The location and orientation of these
residues and secondary structures of the Phe
25-Pro
28 region of the
B-chain were supported by structures derived from MD simula-
tions. Furthermore, the structures showed that all three disulfide
bonds remained intact in the dimer, which models the fibrillar
form of insulin.
Together with the determination of the amino acid sequence
that directly participates in the association and fibrillation of
insulin dimers, we discovered a unique organization of six insulin
cysteine residues, supporting the presence of intact disulfide bonds
and their lack of scrambling during insulin aggregation. These
results indicate that cysteine residues localized on the fibril surface
may play a direct role in free radical formation, which has been
previously described for sulfur atoms in proteins [16].
Twenty out of 51 amino acids in the insulin sequence
demonstrated complete H/D exchange. We determined that 10
residues are hydrophilic and 10 are hydrophobic (Table S1). Thus,
our preliminary estimation of the insulin fibril surface based on
NMR data analysis of unprotected amino acids indicates that it is
equally hydrophilic (polar) and hydrophobic (nonpolar). The
Figure 4. Equilibrated structure of an insulin dimer from 150-ns MD simulations in aqueous solution. The A- and B-chain of the second
monomer are labeled A ` and B `, respectively. Intact disulfide bridges are shown in green.
doi:10.1371/journal.pone.0036989.g004
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underlined by the fact that the fibrillar surface is one of the major
sources of fibrillar toxicity.
Materials and Methods
Fibril Formation
Bovine insulin was purchased from Sigma-Aldrich (I5500).
Insulin fibrillation was performed by growing insulin (60 mg/ml)
in HCl, pH 1.9 at 65uC overnight as previously described [37].
The amyloid fibrils were washed with HCl, pH 1.9 and
centrifuged for 30 min at 12,000 g at 25uC. The supernatant
was removed and the process was repeated twice. The insulin
fibrils were then redispersed in HCl, pH 1.9 and lyophilized. To
prepare a protonated sample, 28 mg of lyophilized powder was
dissolved in d6-DMSO and 0.05% TFA for NMR analysis. To
prepare a deuterated sample, 25 mg of lyophilized powder was
exposed to D2O for 7 days at 20.5uC, followed by lyophilization.
Deuterated lyophilized amyloid fibrils were dissolved in d6-DMSO
and 0.05% TFA for NMR analysis. The final concentrations of the
protonated and deuterated amyloid fibrils were 9 mM and
10 mM, respectively.
NMR Experiments
All samples were placed in a 5-mm NMR tube, and the
experiments were conducted on a Bruker AM-500 spectrometer
with a z-axis gradient cryoprobe. The probe temperature was
maintained at 30uC.
1H,
1H-TOCSY and
1H,
1H NOESY spectra
were collected with a mixing time of 45 ms and 150 ms,
respectively, to optimize magnetization transfer. Spectra were
collected using the Watergate pulse sequence for water suppression
[38]. All spectra were processed using TOPSPIN 2.1 (Bruker, Inc).
In t1 and t2 dimensions, 4096 and 512 points were collected,
Figure 5. Snapshots of insulin dimers from MD simulations. The b-sheet character of each structure is shown in parentheses.
doi:10.1371/journal.pone.0036989.g005
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Fourier transformed. NMR chemical shift assignments were made
using CARA software [39].
To date, the bacterial recombinant expression of mature insulin
is not possible. Homonuclear NMR is the only method available
for assigning protons of insulin. The chemical shift assignments of
dispersed insulin amyloid fibrils were assigned based on known
assignments of the insulin monomer dissolved in 65% H2O, 35%
d3-acetonitrile, and 0.05% TFA [40]. Because the
1H,
1H-TOCSY
spectrum of monomeric insulin was very similar to that of amyloid
fibrils, we used the insulin monomer during chemical shift
assignment experiments. To match the chemical shifts of insulin
under different buffer conditions, 1 mM of insulin monomer was
dissolved in H2O, 35% d3-acetonitrile, and 0.05% TFA, and the
solvent was gradually changed to d6-DMSO and 0.05% TFA. The
changes in the NMR spectra of monomeric insulin were
monitored by
1H,
1H-TOCSY.
Raman Experiments
Non-resonance Raman spectroscopy. Insulin fibrils were
lyophilized and the resulting insulin protein powder was placed
onto alumina foil. A Renishaw inVia confocal Raman spectrom-
eter equipped with a research-grade Leica microscope, 206long-
range objective (numerical aperture of 0.35), and WiRE 2.0
software was used for non-resonance Raman spectroscopy. A 785-
nm-wavelength laser was used, and the laser power was reduced to
approximately 11.5 mW to avoid sample photo-degradation.
Deep UV resonance Raman spectroscopy
(DUVRR). DUVRR spectra (197-nm excitation) were collected
using a home-built Raman spectrometer as previously described
[41]. A spinning quartz NMR tube with a magnetic stirrer inside
was used for sampling. Raman scattering was dispersed and
recorded using a homebuilt double monochromator coupled to a
liquid-nitrogen-cooled CCD camera (Roper Scientific, Inc.). All
reported Raman spectra were an average of at least three
independent measurements. GRAMS/AI 7.0 software (Thermo
Galactic, Salem, NH) was used for data processing. The
application of hydrogen-deuterium exchange combined with
DUVRR spectroscopy for structural characterization of the fibril
core has been previously described. [42] Samples (1 mL) of fibrils
dispersed in water were centrifuged at 140006g for 30 min. The
precipitate was subsequently divided into two parts, each of which
was washed two times with either D2Oo rH 2O by subsequent
spinning-redispersion. The washed dispersions (in D2O and H2O)
were used for Raman spectroscopic measurements.
Dynamic Light Scattering (DLS)
Solutions of insulin protein and insulin fibrils disintegrated by
DMSO/TFA were analyzed using Dyna Pro Titan DLS (Wyatt
Technology Corp.). Acquired data were analyzed using DYNAM-
ICS V6 software (Wyatt Technology Corp.).
Atomic Force Microscopy (AFM)
Fibril solution was centrifuged at 12,000 g prior to the
deposition to remove nonaggregated protein. A gelatinous pellet
was diluted with HCl, pH 1.9 or DCl, pD* 1.9 solution with a
1:400 dilution factor (V/V). A drop of this solution was placed
onto freshly cleaved mica in AFM fluid chamber and incubated for
2 min followed by removing of the solution excess. To avoid mica
surface drying, 2 ml of distill water were placed on the top of the
mica. AFM scanning was performed immediately in tapping mode
using MFP-3D
TM Bio Asylum Research microscope (Asylum
Research, CA, USA) with Olympus TR400PSA tips.
Computational Methods
Using the GROMACS program [43,44], all MD simulations
were performed utilizing the GROMOS force field GROMOS96
53A5 [45]. In the simulations, the starting structures were placed in
a large cubic box (9.067.067.0 A ˚ 3) to avoid artificial interactions
with their images in the neighboring boxes created by the
application of periodic boundary conditions (PBCs). The box was
filled with single point charge (SPC) water molecules. The
GROMOS96 force field and SPC water model have been
successfully employed to explore protein dynamics in several
recent studies (cite 1–3 from the letter of response). Some water
molecules were replaced with sodium and chloride ions to
neutralize the system and to simulate an experimentally used ion
concentration of 150 mM. Subsequently, the starting structures
were energy-minimized with a steepest descent method that used
3000 steps. The results of these minimizations produced the
starting structure for the MD simulations. Subsequently, the
simulations were performed with a constant number of particles
(N), pressure (P) and temperature (T) (i.e., the NPT ensemble). The
SETTLE algorithm [46] was used to constrain the bond lengths
and angles of the water molecules, and the LINCS algorithm [47]
was used to constrain the bond length of the peptide bond. Long-
range electrostatic interactions were calculated by the Particle-
Mesh Ewald (PME) method [48]. A constant pressure of 1 bar was
applied with a coupling constant of 1.0 ps. Peptides, water
molecules and ions were coupled separately to a bath at 300 K
with a coupling constant of 0.1 ps. The equation of motion was
integrated at each 2-fs time step. Umbrella pulling, as implemented
in the GROMACS package, was applied to unfold the monomeric
structure. In this method, a harmonic potential is applied between
the center of mass of two groups. A standard pulling rate and a
force constant of 0.002 nm/ps and 1600 kJ/mol nm
2, respectively,
were used [49]. The tools available in the GROMACS program
package and the YASARA program [50] were used for analyzing
the trajectories and the simulated structures.
Computational Modeling
The monomer X-ray structure of the bovine insulin hexamer
dimer was crystallized from bovine insulin hexamer (PDB ID:
2ZP6). [51] The insulin monomer was abstracted from the X-ray
structure of bovine insulin hexamer (PDB ID: 2ZP6). This
structure was simulated in water without any constraints for
100 ns. In the next step, umbrella pulling was applied on the N-
and C-termini to unfold this structure. The unfolded structure was
then used to prepare a model for the dimer. In the model for the
150-ns simulation, both monomers were oriented to form a zipper-
like conformation. The most representative structure obtained
from this simulation was further utilized to develop 10-ns MD
simulations for the insulin hexamer. In this model, the B6L-B20G
and A5Q-A21N fragments of each monomer were truncated.
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